These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 4394830)
1. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent. Ferrini R; Miragoli G; Croce G Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830 [No Abstract] [Full Text] [Related]
2. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent]. Brunner H; Hedwall PR; Meier M Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373 [No Abstract] [Full Text] [Related]
3. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)]. Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist. Levy JV J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374 [No Abstract] [Full Text] [Related]
5. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent. Tachikawa S; Takenaka T Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371 [No Abstract] [Full Text] [Related]
6. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug. Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548 [No Abstract] [Full Text] [Related]
7. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366. Baum T; Rowles G; Shropshire AT; Gluckman MI J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186 [No Abstract] [Full Text] [Related]
8. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent. Darias V; del Río J Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633 [No Abstract] [Full Text] [Related]
9. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. Giudicelli JF; Schmitt H; Boissier JR J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677 [No Abstract] [Full Text] [Related]
10. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)]. Nakanishi M; Imamura H; Nakamura T; Kimura T Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075 [No Abstract] [Full Text] [Related]
11. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system. Nayler WG; Tay J J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889 [No Abstract] [Full Text] [Related]
12. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219. Caputi AP; Marmo E; Saini RK Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996 [No Abstract] [Full Text] [Related]
13. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366. Baum T; Rowles G; Shropshire AT J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546 [No Abstract] [Full Text] [Related]
14. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol). Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603 [No Abstract] [Full Text] [Related]
15. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers. Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist. Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372 [No Abstract] [Full Text] [Related]
17. [Pharmacological study of a new beta adrenergic inhibitor (S 2395)]. Laubie M; Schmitt H; Mouillé P; Cheymol G; Gilbert JC C R Acad Hebd Seances Acad Sci D; 1971 Oct; 273(14):1234-6. PubMed ID: 4399407 [No Abstract] [Full Text] [Related]
19. The effect of alkyl substitution in drugs. XIX. Synthesis and pharmacological properties of a series of 1-(diarylmethoxy)-3-(isopropylamino)-2-propanol hydrochlorides showing antiarrhythmic activity. De Vries J; Nauta WT; Timmerman H; van Hell G; Mulder D Arzneimittelforschung; 1968 Sep; 18(9):1200-3. PubMed ID: 5755937 [No Abstract] [Full Text] [Related]
20. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46]. Yoshida T; Takano M; Tamura A; Kubota H; Suzuki N Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894 [No Abstract] [Full Text] [Related] [Next] [New Search]